5:59 PM
 | 
Jan 14, 2013
 |  BC Extra  |  Financial News

InterMune, Alnylam propose follow-ons

InterMune Inc. (NASDAQ:ITMN) and Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) proposed follow-ons late Monday. InterMune said it plans to raise a total of about $210 million through the sale of 12.5 million shares in a follow-on...

Read the full 158 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >